• Something wrong with this record ?

Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine

A. Ligasová, R. Liboska, D. Friedecký, K. Mičová, T. Adam, T. Oždian, I. Rosenberg, K. Koberna,

. 2016 ; 6 (1) : 150172.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NV15-31604A MZ0 CEP Register

5-Ethynyl-2'-deoxyuridine (EdU) and 5-ethynyl-2'-deoxycytidine (EdC) are mainly used as markers of cellular replicational activity. Although EdU is employed as a replicational marker more frequently than EdC, its cytotoxicity is commonly much higher than the toxicity of EdC. To reveal the reason of the lower cytotoxicity of EdC, we performed a DNA analysis of five EdC-treated human cell lines. Surprisingly, not a single one of the tested cell lines contained a detectable amount of EdC in their DNA. Instead, the DNA of all the cell lines contained EdU. The content of incorporated EdU differed in particular cells and EdC-related cytotoxicity was directly proportional to the content of EdU. The results of experiments with the targeted inhibition of the cytidine deaminase (CDD) and dCMP deaminase activities indicated that the dominant role in the conversion pathway of EdC to EdUTP is played by CDD in HeLa cells. Our results also showed that the deamination itself was not able to effectively prevent the conversion of EdC to EdCTP, the conversion of EdC to EdCTP occurs with much lesser effectivity than the conversion of EdU to EdUTP and the EdCTP is not effectively recognized by the replication complex as a substrate for the synthesis of nuclear DNA.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000683
003      
CZ-PrNML
005      
20201105083836.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1098/rsob.150172 $2 doi
024    7_
$a 10.1098/rsob.150172 $2 doi
035    __
$a (PubMed)26740587
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Ligasová, Anna $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic anna.ligasova@upol.cz.
245    10
$a Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine / $c A. Ligasová, R. Liboska, D. Friedecký, K. Mičová, T. Adam, T. Oždian, I. Rosenberg, K. Koberna,
520    9_
$a 5-Ethynyl-2'-deoxyuridine (EdU) and 5-ethynyl-2'-deoxycytidine (EdC) are mainly used as markers of cellular replicational activity. Although EdU is employed as a replicational marker more frequently than EdC, its cytotoxicity is commonly much higher than the toxicity of EdC. To reveal the reason of the lower cytotoxicity of EdC, we performed a DNA analysis of five EdC-treated human cell lines. Surprisingly, not a single one of the tested cell lines contained a detectable amount of EdC in their DNA. Instead, the DNA of all the cell lines contained EdU. The content of incorporated EdU differed in particular cells and EdC-related cytotoxicity was directly proportional to the content of EdU. The results of experiments with the targeted inhibition of the cytidine deaminase (CDD) and dCMP deaminase activities indicated that the dominant role in the conversion pathway of EdC to EdUTP is played by CDD in HeLa cells. Our results also showed that the deamination itself was not able to effectively prevent the conversion of EdC to EdCTP, the conversion of EdC to EdCTP occurs with much lesser effectivity than the conversion of EdU to EdUTP and the EdCTP is not effectively recognized by the replication complex as a substrate for the synthesis of nuclear DNA.
650    _2
$a protilátky $x metabolismus $7 D000906
650    _2
$a bromodeoxyuridin $x metabolismus $7 D001973
650    _2
$a buněčná smrt $7 D016923
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčné jádro $x metabolismus $7 D002467
650    _2
$a cytidindeaminasa $x metabolismus $7 D003564
650    _2
$a DNA $x metabolismus $7 D004247
650    _2
$a replikace DNA $7 D004261
650    _2
$a deoxycytidin $x analogy a deriváty $x metabolismus $7 D003841
650    _2
$a deoxyuridin $x analogy a deriváty $x metabolismus $7 D003857
650    _2
$a lidé $7 D006801
650    _2
$a metabolom $7 D055442
650    _2
$a malá interferující RNA $x metabolismus $7 D034741
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Liboska, Radek $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
700    1_
$a Friedecký, David $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
700    1_
$a Mičová, Kateřina $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
700    1_
$a Adam, Tomáš, $d 1965- $7 xx0054162 $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
700    1_
$a Oždian, Tomáš $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic.
700    1_
$a Rosenberg, Ivan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, v.v.i., Prague 16610, Czech Republic.
700    1_
$a Koberna, Karel $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Olomouc 77900, Czech Republic karel.koberna@upol.cz.
773    0_
$w MED00190574 $t Open biology $x 2046-2441 $g Roč. 6, č. 1 (2016), s. 150172
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26740587 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20201105083833 $b ABA008
999    __
$a ok $b bmc $g 1179823 $s 961250
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 6 $c 1 $d 150172 $i 2046-2441 $m Open biology $n Open Biol $x MED00190574
GRA    __
$a NV15-31604A $p MZ0
LZP    __
$a Pubmed-20170103

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...